Journal article icon

Journal article

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.

Abstract:

BACKGROUND: The efficacy of bacille Calmette-Guérin (BCG) may be enhanced by heterologous vaccination strategies that boost the BCG-primed immune response. One leading booster vaccine, MVA85A (where "MVA" denotes "modified vaccinia virus Ankara"), has shown promising safety and immunogenicity in human trials performed in the United Kingdom. We investigated the safety and immunogenicity of MVA85A in mycobacteria-exposed--but Mycobacterium tuberculosis-uninfected--healthy adults from a region ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1086/590185

Authors


Expand authors...
Journal:
The Journal of infectious diseases
Volume:
198
Issue:
4
Pages:
544-552
Publication date:
2008-08-05
DOI:
EISSN:
1537-6613
ISSN:
0022-1899
URN:
uuid:9394e83f-bc56-424e-8f14-6fa737c5ee81
Source identifiers:
40815
Local pid:
pubs:40815

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP